iFuse Bedrock Granite iFuse Bedrock GraniteSANTA CLARA, Calif., May 31, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based...
-- Overall survival (OS) for patients with metastatic, microsatellite stable colorectal cancer (MSS-CRC) who had two prior lines of therapy...
LOS ANGELES, May 31, 2022 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and...
BIIB122 is an inhibitor of LRRK2, a potential novel target intended to impact the underlying biology and slow the progression...
SAN JOSE, Calif., May 31, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR) (the “Company” or “Eargo”), a medical device...
Ayujoy Herbals Ltd. and Anthea, Inc. Announce Product Sourcing and Marketing Collaboration MAG Mountain WaterBerlin, Germany, May 31, 2022 (GLOBE...
Promising preliminary clinical results validate expansion of study initially into the United KingdomFLORHAM PARK, N.J., May 31, 2022 (GLOBE NEWSWIRE)...
BOSTON, May 31, 2022 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics...
Updated data from Phase 1/2a study show median duration of response greater than 21 months and median progression-free survival of...
LOS ANGELES, May 31, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) - Enochian BioSciences is working to solve our greatest public...
Suppression of diurnal, or daily, fluctuations in IOP, is a significant and independent risk factor for the progression of glaucomaThese...
Ovarian Cancer ID8 Study – Survival Probability Source imageStand-alone therapy with PD1 checkpoint inhibitors has shown limited efficacy against ovarian...
LAKEWOOD, Colo., May 31, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the fourth quarter (“4Q22”)...
AXS-05 (dextromethorphan-bupropion) demonstrated rapid, substantial, and statistically significant antidepressant efficacy compared to placebo starting 1 week after treatmentNEW YORK, May...
MONTREAL, May 31, 2022 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or “the Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company...
SAN DIEGO, May 31, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (Nasdaq:BTX) (“Brooklyn” or the “Company”), a biopharmaceutical company focused...
GAITHERSBURG, Md., May 31, 2022 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Dr....
BOCA RATON, Fla., May 31, 2022 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF),...
New PDUFA goal date of December 28, 2022NEW YORK, May 31, 2022 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today...
Vancouver, British Columbia--(Newsfile Corp. - May 31, 2022) - Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) ("Bloom"...